Bernstein Lifts Price Target on CVS Health to $63 From $62
CVS Health Analyst Ratings
Truist Financial Maintains CVS Health(CVS.US) With Buy Rating, Announces Target Price $67
Truist Financial Remains a Buy on CVS Health (CVS)
Truist Lowers Price Target on CVS Health to $67 From $76, Keeps Buy Rating
Leerink Partners Maintains CVS Health(CVS.US) With Hold Rating, Cuts Target Price to $57
Evercore Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $75
CVS Health: Strategic Board Enhancements and Undervaluation Drive Buy Rating
CVS Health Price Target Raised to $66.00/Share From $60.00 by Wells Fargo
CVS Health Raised to Overweight From Equal-Weight by Wells Fargo
Wells Fargo Upgrades CVS Health to Overweight From Equalweight, Adjusts Price Target to $66 From $60
CVS Health Is Maintained at Outperform by RBC Capital
CVS Health Analyst Ratings
RBC Capital Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $58
RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)
J.P. Morgan Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $80
JPMorgan Adjusts Price Target on CVS Health to $80 From $86, Keeps Overweight Rating
J.P. Morgan Reaffirms Their Buy Rating on CVS Health (CVS)
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $73
TD Cowen Cuts Price Target on CVS Health to $73 From $85